NASDAQ · Healthcare · Biotechnology
Ultragenyx Pharmaceutical Inc.
RARE
Ultragenyx Pharmaceutical Inc. CEO Emil D. Kakkis · Market cap $2.6B.
$26.13
+0.20 · +0.77%
52w hi $42.3752w lo $18.29
44
ROUTINE
Current InsiderScore
Corp · 90d
1
0 buys · 1 sales
Cong · 90d
1
1 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 02 | Emil D Kakkis | President & CEO | Sell | 54,404 | $22.80 | −$1.24M | 34 |
Section 02
Recent STOCK Act disclosures
1 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Mar 10 | Gilbert Cisneros | House · CA | Buy | $1,001 - $15,000 | $8K | 20 d | 44 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay